FDA 483 - Labcorp Early Development Laboratories, Inc. - May 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Labcorp Early Development Laboratories, Inc. in Madison, WI, revealed a significant Good Laboratory Practice (GLP) deficiency. The study director failed to ensure the complete transfer of raw data, documentation, and reports, specifically Immunology and Immunotoxicity data, to the archives at the close of a study. This included a failure to perform required Quality Control on the data before archiving, indicating a lapse in regulatory compliance for data management.
- Person
ID · bcd31976-ca2e-4df8-a964-efc5e47f2017